These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7545499)

  • 21. Vaccination of dogs with six different candidate leishmaniasis vaccines composed of a chimerical recombinant protein containing ribosomal and histone protein epitopes in combination with different adjuvants.
    Poot J; Janssen LH; van Kasteren-Westerneng TJ; van der Heijden-Liefkens KH; Schijns VE; Heckeroth A
    Vaccine; 2009 Jul; 27(33):4439-46. PubMed ID: 19500553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients.
    Rafati S; Gholami E; Hassani N; Ghaemimanesh F; Taslimi Y; Taheri T; Soong L
    Vaccine; 2007 May; 25(21):4159-69. PubMed ID: 17395340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The IgG isotypes of specific antibodies in patients with American cutaneous leishmaniasis; relationship to the cell-mediated immune response.
    Rodríguez V; Centeno M; Ulrich M
    Parasite Immunol; 1996 Jul; 18(7):341-5. PubMed ID: 9229387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leishmanial amastigote antigen P-2 induces major histocompatibility complex class II-dependent natural killer-cell reactivity in cells from healthy donors.
    Nylén S; Maasho K; McMahon-Pratt D; Akuffo H
    Scand J Immunol; 2004 Mar; 59(3):294-304. PubMed ID: 15030581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
    Bretscher PA; Ogunremi O; Menon JN
    Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serial study of the immune response of an individual with exacerbated simple cutaneous leishmaniasis.
    Klaus SN; Frankenburg S; Gross A; Jonas F; Vardy D
    Isr J Med Sci; 1994 Jan; 30(1):19-21. PubMed ID: 8138392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis.
    Silveira FT; Lainson R; De Castro Gomes CM; Laurenti MD; Corbett CE
    Parasite Immunol; 2009 Aug; 31(8):423-31. PubMed ID: 19646206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reviewing the role of the dendritic Langerhans cells in the immunopathogenesis of American cutaneous leishmaniasis.
    Silveira FT; Lainson R; Gomes CM; Laurenti MD; Corbett CE
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1075-80. PubMed ID: 18602127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen-reactive gamma delta T cells in human leishmaniasis.
    Russo DM; Armitage RJ; Barral-Netto M; Barral A; Grabstein KH; Reed SG
    J Immunol; 1993 Oct; 151(7):3712-8. PubMed ID: 8376802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigen-stimulated lymphokines from patients with cutaneous leishmaniasis induce monocyte killing of Leishmania major intracellular amastigotes.
    Passwell JH; Shor R; Trau H; Shoham J; Jaffe CL
    J Immunol; 1987 Dec; 139(12):4208-12. PubMed ID: 3121732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Profile of human T cell response to leishmanial antigens. Analysis by immunoblotting.
    Melby PC; Neva FA; Sacks DL
    J Clin Invest; 1989 Jun; 83(6):1868-75. PubMed ID: 2470787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship of Leishmania braziliensis subspecies and immune response to disease expression in New World leishmaniasis.
    Saravia NG; Valderrama L; Labrada M; Holguín AF; Navas C; Palma G; Weigle KA
    J Infect Dis; 1989 Apr; 159(4):725-35. PubMed ID: 2647862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leishmania major: species specific delayed hypersensitivity reaction induced by exogenous secreted antigen in the guinea pig.
    Khabiri AR; Bagheri F; Assmar M
    Exp Parasitol; 2006 Mar; 112(3):184-6. PubMed ID: 16376333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.
    Bottrel RL; Dutra WO; Martins FA; Gontijo B; Carvalho E; Barral-Netto M; Barral A; Almeida RP; Mayrink W; Locksley R; Gollob KJ
    Infect Immun; 2001 May; 69(5):3232-9. PubMed ID: 11292745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
    Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
    Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapy as a strategy for treatment of leishmaniasis: a review of the literature.
    Okwor I; Uzonna JE
    Immunotherapy; 2009 Sep; 1(5):765-76. PubMed ID: 20636022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leishmaniasis: Immunological and clinical aspects and vaccines in Venezuela.
    Convit J
    Clin Dermatol; 1996; 14(5):479-87. PubMed ID: 8889325
    [No Abstract]   [Full Text] [Related]  

  • 38. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
    Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
    Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4+ type 1 and CD8+ type 2 T cell subsets in human leishmaniasis have distinct T cell receptor repertoires.
    Uyemura K; Pirmez C; Sieling PA; Kiene K; Paes-Oliveira M; Modlin RL
    J Immunol; 1993 Dec; 151(12):7095-104. PubMed ID: 7903101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demonstration of an indomethacin-sensitive mechanism regulating immune reactivity in American cutaneous leishmaniasis patients.
    Castes M; Trujillo D; Scott D; Rondon AJ
    Clin Exp Immunol; 1987 Aug; 69(2):280-90. PubMed ID: 3652533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.